# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-12T14:36:23.655986
**Route:** OpenRouter + LaTeX
**Tokens:** 30465 in / 1492 out
**Response SHA256:** f1a2ddff0755c3f5

---

I reviewed the draft with the four fatal-error categories you specified (Data-Design Alignment, Regression Sanity, Completeness, Internal Consistency). I focused only on FATAL issues (those that would make the paper impossible to defend or obviously wrong at submission). I found no fatal errors.

Checks performed (high level)

- Data-Design Alignment
  - Treatment timing vs. data coverage: The stated data coverage (monthly Jan 2000 – Jun 2024) covers the Great Recession peak (Dec 2007) and trough and the COVID peak (Feb 2020) and the post-treatment windows used (up to 120 months after GR peak and up to 52 months after COVID peak). Max treatment year ≤ max data year holds.
  - Post-treatment observations: The paper reports and uses post-treatment horizons for both episodes (GR: up to 120 months; COVID: up to 52 months). The sample restrictions (46 states for GR because of FHFA availability; 48 contiguous states for COVID) are consistently stated and line up with the instruments used.
  - Treatment definition consistency: The housing-boom measure (2003Q1–2006Q4) and Bartik constructions (2019 shares for COVID) are clearly defined and used consistently across tables and text.

- Regression Sanity
  - I scanned reported coefficient and standard-error magnitudes in the main text and appendix tables. Coefficients and SEs are of plausible magnitudes for the outcome variables (log employment changes, unemployment rates, participation rates). No SEs or coefficients are orders of magnitude implausible (no SE > 1000; no |coef| > 100 for outcomes where that would be impossible). Reported R² values are within [0,1] where stated. No NA/Inf/negative-SE entries are presented.
  - Inference procedures are described (HC1, permutation tests, cluster checks) and sample sizes (N=46 or 48) are reported in tables.

- Completeness
  - I found no “TBD”, “TODO”, “PLACEHOLDER”, “NA” placeholders in the main text or appendix tables that would indicate incomplete work.
  - Regression tables include (or are stated to include) standard errors and sample sizes. The main empirical results show standard errors and p-values; the paper reports robustness checks and appendices for additional analyses.
  - Figures/tables referenced in text appear to be defined and described; table numbers and appendix references are present.

- Internal Consistency
  - Sample descriptions are consistent across sections (balanced panel Jan 2000–Jun 2024, GR sample 46 states due to FHFA, COVID sample 48 states).
  - Treatment timing is consistently described (GR peak Dec 2007; COVID peak Feb 2020) and used to define horizons.
  - Numbers cited in the text (example: coefficients, half-lives) match the numbers shown in tables/appendix (the places where coefficients and SEs are explicitly reported).

ADVISOR VERDICT: PASS